CoChat

Biallelic variants in the RNA exosome gene EXOSC5 are associated with developmental delays, short stature, cerebellar hypoplasia and motor weakness

Open access

Published version of a preprint

The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index; none of the 62 sources its claims cite is checked for support yet.

Abstract

The RNA exosome is an essential ribonuclease complex required for processing and/or degradation of both coding and non-coding RNAs. We identified five patients with biallelic variants in EXOSC5, which encodes a structural subunit of the RNA exosome. The clinical features of these patients include failure to thrive, short stature, feeding difficulties, developmental delays that affect motor skills, hypotonia and esotropia. Brain MRI revealed cerebellar hypoplasia and ventriculomegaly. While we ascertained five patients, three patients with distinct variants of EXOSC5 were studied in detail. The first patient had a deletion involving exons 5–6 of EXOSC5 and a missense variant, p.Thr114Ile, that were inherited in trans, the second patient was homozygous for p.Leu206His and the third patient had paternal isodisomy for chromosome 19 and was homozygous for p.Met148Thr. The additional two patients ascertained are siblings who had an early frameshift mutation in EXOSC5 and the p.Thr114Ile missense variant that were inherited in trans. We employed three complementary approaches to explore the requirement for EXOSC5 in brain development and assess consequences of pathogenic EXOSC5 variants. Loss of function for exosc5 in zebrafish results in shortened and curved tails/bodies, reduced eye/head size and edema. We modeled pathogenic EXOSC5 variants in both budding yeast and mammalian cells. Some of these variants cause defects in RNA exosome function as well as altered interactions with other RNA exosome subunits. These findings expand the number of genes encoding RNA exosome subunits linked to human disease while also suggesting that disease mechanism varies depending on the specific pathogenic variant.

Overview

CoChat Summary

TL;DR

Biallelic EXOSC5 variants were identified in five patients with developmental delays, short stature, cerebellar hypoplasia and motor weakness, with three patients characterized in detail. Functional studies in zebrafish, budding yeast and mammalian cells indicate EXOSC5 is required for neurodevelopment and that distinct pathogenic variants impair RNA exosome function through different mechanisms.

Key findings

  • Five patients had biallelic EXOSC5 variants; core features included failure to thrive, short stature, feeding difficulties, motor developmental delays, hypotonia and esotropia, with brain MRI showing cerebellar hypoplasia and ventriculomegaly. Heights ranged from 0 to 9th centiles in the detailed patients, and all patients had height <10th centile.
  • Variants included a deletion of exons 5–6 plus p.Thr114Ile in trans (Patient 1), homozygous p.Leu206His (Patient 2), and paternal isodisomy for chromosome 19 with homozygous p.Met148Thr (Patient 3); two additional siblings had a frameshift c.87del (p.His30Thrfs*35) and p.Thr114Ile.
  • Zebrafish exosc5 CRISPR/Cas9 targeting caused shortened/curved tails and bodies, reduced eye/head size and edema; targeted larvae did not survive to breeding age and died within a few weeks. In Figure 2B, exosc5 crispants (n=226) showed overrepresentation of mild, moderate and severe phenotypes compared with uninjected controls (n=230).
  • Yeast rrp46-L191H (modeling p.Leu206His) showed growth defects at 30 and 37°C, with doubling times ~133 min at 30°C (64% longer than control) and ~169 min at 37°C (69% longer), plus accumulation of U4 snRNA precursor (P=0.0068) and TLC1 precursor (P=0.0008) and impaired 7S pre-rRNA processing. Mammalian EXOSC5 p.Leu206His showed minimal interaction with EXOSC3 (9%), EXOSC9 (16%) and EXOSC10 (21%); p.Thr114Ile showed decreased interaction (28%, 24%, 40%); p.Met148Thr was comparable to wild-type, and steady-state protein levels were not significantly altered.

Methods

  • Clinical exome sequencing was performed in five patients; Patients 1 and 3 underwent trio exome sequencing, and Patient 2 underwent exome sequencing with both parents, with variant filtering.
  • Zebrafish CRISPR/Cas9 targeted exon 2 of exosc5 in EKW, mnx1:EGFP and NBT:DsRed strains; larvae were assessed for morphology, histology and exosc5 expression by qRT-PCR.
  • Budding yeast rrp46Δ strains expressed wild-type Rrp46 or Q86I, L127T or L191H variants; growth assays, immunoblotting, RT-qPCR for U4/TLC1 precursors and northern blotting for 7S pre-rRNA were performed. Mammalian Neuro2A cells expressed Myc-tagged mouse EXOSC5 wild-type or T114I, M148T or L206H variants for immunoblotting and co-immunoprecipitation with EXOSC3, EXOSC9 and EXOSC10; structural modeling used PDB 6h25 and mCSM.

Limitations

  • Stated: the full spectrum of clinical findings and any phenotype–genotype correlation for EXOSC5 are not yet known; the mechanistic basis for altered function of EXOSC5 p.Met148Thr remains unclear; future studies in patient samples and relevant cell types are needed.
  • Stated: zebrafish F0 larvae with exosc5 targeting did not survive to breeding age and were not examined for later phenotypes; the additional sibling pair had limited case descriptions; Patients 2 and 3 were not evaluated for retinal degeneration; the third patient's phenotype may have been influenced by isodisomy for additional autosomal recessive genes.
  • Evident: co-immunoprecipitation quantitation was based on a single immunoblot (though representative of multiple experiments); the patient number is small (five, with three detailed) and no patient-derived tissue functional studies were performed; the yeast model showed clear functional defects only for rrp46-L191H, so variant-specific mechanisms may not be fully captured.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1093/hmg/ddaa108

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 Valid · 0 Not valid · 44 Not checked · 154 Own results and interpretations

74 more claims

Create a free account to see all 198 claims and to verify the 54 references still open.

See all claims — free account
  • It may state two separate claims as one. 87
  • Probably not a substantial claim. 52
  • The quote only partly states this claim. 3

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

6 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

5 of 6 · the rest aren’t loaded

1 more finding

Create a free account to see every finding of this check.

See all findings — free account

Citations

Cites

Research works printed but not linked: 3

  1. Sorlien, E.L., Witucki, M.A. and Ogas, J. (2018) Efficient pro- duction and identification of CRISPR/Cas9-generated gene knockouts in the model system Danio rerio. J. Vis. Exp., 138, 56969.
  2. Eggens, V.R., Barth, P. and Baas, F. (2014) In Adam, M.P., Ardinger, H.H., Pagon, R.A., Wallace, S.E., Bean, L.J.H., Mef- ford, H.C., Stephens, K., Amemiya, A. and Ledbetter, N. (eds) EXOSC3-Related Pontocerebellar Hypoplasia, GeneRe- views [Internet]. University of Washington, Seattle, WA.
  3. Klebe, R.J. and Ruddle, F.H. (1969) Neuroblastoma: cell culture analysis of a differentiating stem cell system. J. Cell Biol., 43, 69a.

Cited by

See all 39

Metadata

Authors
Slavotinek, A., Misceo, D., Htun, S., Mathisen, L., Frengen, E., Foreman, M., Hurtig, J. E., Enyenihi, L., Sterrett, M. C., Leung, S. W., Schneidman-Duhovny, D., Estrada-Veras, J., Duncan, J. L., Haaxma, C. A., Kamsteeg, E.-J., Xia, V., Beleford, D., Si, Y., Douglas, G., Treidene, H. E., van Hoof, A., Fasken, M. B., & Corbett, A. H.
Affiliations
  • University of California, San Francisco (US)
  • Oslo University Hospital (NO)
  • The University of Texas Health Science Center at Houston (US)
  • Emory University (US)
  • School of Computer Science and Engineering and the Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem 91904, Israel
  • Department of Pediatrics—Medical Genetics and Metabolism, Uniformed Services University/Walter Reed NMMC Bethesda, MD 20889, USA
  • Radboud University Nijmegen (NL)
  • Radboud University Medical Center (NL)
  • GeneDx Inc., MD 20877, USA
Corresponding author
  • Slavotinek, Anne
  • Corbett, Anita H
Venue
Human Molecular Genetics
Published
2020-06-05
Volume
29
Issue
13
Pages
2218-2239
ISSN
  • 0964-6906 (ISSN-L)
  • 1460-2083
OpenAlex
W3033203285
Cited by
38
References
69
Citations by year
2026: 12 · 2025: 7 · 2024: 4 · 2023: 5 · 2022: 5 · 2021: 3 · 2020: 2
FWCI
0.96
Type
journal article
Language
en
Open access
Locations
  • Human Molecular Genetics (publishedVersion)
  • bioRxiv (Cold Spring Harbor Laboratory) (submittedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
  • Radboud Repository (Radboud University) (submittedVersion)
  • NORA - Norwegian Open Research Archives (submittedVersion, other-oa)
Funders
  • National Institutes of Health (1F31GM134649, U01HG009599, R01 GM130147)
  • Research to Prevent Blindness
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
Keywords
RNA exosome, biallelic variants, developmental delay, short stature, cerebellar hypoplasia, motor weakness, hypotonia, esotropia, ventriculomegaly, failure to thrive, paternal isodisomy, frameshift mutation, missense mutations, loss of function, zebrafish model, yeast model, brain development
MeSH terms
Animals, Antigens, Neoplasm, Cerebellum, Developmental Disabilities, Dwarfism, Homozygote, Humans, Nervous System Malformations, Pedigree, Zebrafish, Frameshift Mutation, RNA-Binding Proteins, Mutation, Missense, Exosome Multienzyme Ribonuclease Complex

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-22, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-22 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.